felin
infecti
periton
fip
common
diseas
frequent
reason
referr
approxim
everi
new
felin
case
present
american
veterinari
teach
hospit
repres
cat
fip
also
major
factor
kitten
mortal
fip
fatal
immunemedi
diseas
trigger
infect
felin
coronaviru
fcov
fcov
belong
famili
coronavirida
group
envelop
positivestrand
rna
virus
frequent
found
cat
coronavirusspecif
antibodi
present
cat
catteri
singlecat
household
approxim
fcovinfect
cat
develop
fip
catteri
situat
howev
fip
common
deadli
effect
longterm
manag
rapid
reliabl
diagnosi
critic
prognost
reason
reliabl
diagnost
test
would
lessen
suffer
affect
patient
avoid
euthanasia
unaffect
cat
howev
unfortun
test
current
avail
difficulti
definit
diagnos
fip
aris
nonspecif
clinic
sign
lack
pathognomon
hematolog
biochem
abnorm
low
sensit
specif
test
routin
use
practic
initi
hypothes
fcov
strain
caus
fip
differ
avirul
enter
fcov
strain
former
strain
howev
serolog
genet
indistinguish
repres
virul
variant
viru
rather
separ
viru
speci
known
cat
infect
primarili
avirul
fcov
replic
enterocyt
instanc
howev
mutat
occur
certain
region
fcov
genom
lead
abil
viru
replic
within
macrophag
seem
key
pathogen
event
develop
fip
produc
even
question
still
answer
object
articl
review
recent
knowledg
increas
understand
complex
pathogenesi
fip
diseas
fip
first
describ
syndrom
cat
character
immunemedi
vascul
pyogranulomat
inflammatori
reaction
viru
identifi
etiolog
agent
classifi
coronaviru
label
felin
infecti
periton
viru
fipv
fip
becom
increasingli
import
diseas
veterinarian
must
consid
account
infecti
diseaserel
death
pet
cat
thu
take
titl
recent
year
felin
leukemia
viru
felv
infect
decreas
preval
import
possibl
explan
increas
preval
fip
manag
domest
cat
chang
introduct
litter
box
cat
kept
perman
indoor
expos
larg
dose
fcov
fece
would
previous
buri
outdoor
cat
spend
part
life
crowd
environ
cat
breeder
shelter
increas
stress
exposur
fcov
environ
coronavirus
caus
harmless
mostli
clinic
inappar
enter
infect
cat
also
caus
fip
earlier
day
common
hypothesi
two
differ
coronavirus
exist
cat
felin
enter
coronaviru
fecv
fipv
sinc
becom
known
fipv
develop
fecv
spontan
within
infect
cat
virus
ident
regard
antigenet
properti
except
singl
mutat
genet
properti
differ
regard
pathogen
term
felin
coronaviru
fcov
use
describ
coronavirus
cat
fcov
rna
viru
belong
genu
coronaviru
famili
coronavirida
coronavirus
pleomorph
envelop
particl
averag
nm
diamet
rang
nm
contain
singlestrand
rna
characterist
petalshap
project
call
peplom
rang
nm
protrud
viral
surfac
peplom
respons
crownlik
corona
appear
viru
visual
electron
microscop
led
term
coronaviru
peplom
protein
use
viru
attach
cellular
surfac
protein
act
receptor
viru
shape
bind
specif
topic
enterocyt
replic
nonmut
fcov
thu
primarili
restrict
enterocyt
mutat
fipcaus
fcov
broader
cell
spectrum
includ
macrophag
fcov
belong
taxonom
cluster
coronavirus
transmiss
gastroenter
viru
tgev
porcin
respiratori
coronaviru
canin
coronaviru
ccv
human
coronavirus
mani
speci
anim
coronavirus
rel
restrict
organ
tropism
mainli
infect
respiratori
gastrointestin
cell
cat
mice
howev
coronaviru
infect
certain
circumst
involv
sever
organ
coronavirus
rel
low
speci
specif
ccv
caus
diarrhea
dog
close
relat
fcov
also
infect
cat
contact
ccvcontain
dog
fece
cat
develop
antibodi
crossreact
fcov
one
ccv
strain
induc
diarrhea
laboratori
cat
experiment
infect
cat
infect
anoth
ccv
strain
histolog
chang
ident
chang
typic
seen
enter
fcov
infect
detect
one
studi
ccv
even
caus
fip
depend
antigenet
relat
ccv
fcov
strain
classifi
subtyp
serotyp
serotyp
ii
antibodi
ccv
neutral
fcov
serotyp
ii
fcov
serotyp
fcov
serotyp
ii
strain
genet
close
relat
ccv
fcov
serotyp
strain
fcov
serotyp
ii
strain
seem
arisen
recombin
fcov
serotyp
strain
ccv
asid
differ
degre
neutral
antisera
ccv
serotyp
ii
differ
growth
characterist
cell
cultur
cytopathogen
vitro
fcov
serotyp
strain
difficult
grow
cell
cultur
caus
slowli
develop
cytopathogen
effect
fcov
serotyp
ii
strain
howev
grow
rapidli
produc
pronounc
cytopathogen
effect
serotyp
preval
serotyp
field
infect
isol
fcov
strain
field
unit
state
europ
belong
serotyp
japan
howev
serotyp
ii
predomin
cat
fip
infect
fcov
serotyp
serotyp
caus
fip
howev
caus
clinic
inappar
fcov
infect
fcov
fip
major
problem
multiplecat
household
much
lesser
extent
freeroam
cat
fcov
distribut
worldwid
household
wild
cat
viru
endem
especi
environ
mani
cat
kept
togeth
small
space
eg
catteri
shelter
pet
store
virtual
multiplecat
household
without
endem
fcov
least
cat
unit
state
europ
antibodi
coronavirus
switzerland
breed
cat
freeroam
cat
test
posit
antibodi
great
britain
show
cat
cat
breed
institut
cat
singlecat
household
antibodi
fcov
rel
rare
freeroam
ownerless
cat
stray
cat
usual
loner
without
close
contact
importantli
use
locat
dump
fece
major
rout
transmiss
multiplecat
household
studi
gainesvil
florida
adult
feral
cat
trapneuterreturn
program
test
antibodi
coronaviru
sera
neg
confirm
cat
infect
anoth
studi
feral
cat
test
time
brought
local
shelter
multipl
cat
kept
togeth
interv
thereaft
time
enter
small
number
cat
antibodi
approxim
percentag
howev
increas
rapidli
virtual
cat
shelter
infect
fcov
although
preval
fcov
infect
high
approxim
cat
multiplecat
household
situat
develop
fip
number
even
lower
singlecat
environ
risk
develop
fip
higher
young
immunecompromis
cat
replic
fcov
anim
less
control
critic
mutat
thu
like
occur
half
cat
fip
younger
month
age
fcov
also
import
pathogen
nondomest
felid
kennedi
et
al
found
evid
fcov
infect
investig
nondomest
felid
southern
africa
includ
anim
wild
popul
anim
captiv
also
high
incid
fip
wild
felid
captiv
unit
state
europ
eg
zoo
cheetah
highli
suscept
develop
fip
genet
defici
cellular
immun
thought
predispos
diseas
infect
usual
take
place
oronas
cat
usual
infect
nonpathogen
fcov
fcovcontain
fece
shed
cat
harmless
fcov
enter
infect
cat
fip
mutat
fipcaus
fcov
found
secret
excret
cat
fip
thu
transmiss
mutat
fipcaus
fcov
consid
unlik
natur
circumst
fipcaus
fcov
howev
transmit
iatrogen
experiment
condit
exampl
effus
cat
fip
contain
infect
macrophag
inject
naiv
cat
fcov
rel
fragil
viru
inactiv
room
temperatur
within
hour
dri
condit
eg
carpet
shown
surviv
week
outsid
cat
indirect
fomit
transmiss
thu
possibl
viru
transmit
cloth
toy
groom
tool
organ
homogen
even
resist
repeat
freez
c
mani
month
viru
destroy
household
disinfect
deterg
howev
common
mode
infect
viruscontain
fece
thu
major
sourc
fcov
uninfect
cat
litter
box
share
infect
cat
multipl
cat
use
litter
box
readili
infect
continu
reinfect
contamin
litter
box
cat
alreadi
infect
also
seem
play
import
role
endem
surviv
viru
rare
viru
transmit
saliva
mutual
groom
share
food
bowl
close
contact
sneez
droplet
transmiss
also
possibl
whether
fcov
transmiss
occur
signific
degre
cat
show
still
point
discuss
one
survey
attend
cat
show
seem
factor
minor
signific
affect
incid
fip
anoth
survey
cat
show
unit
kingdom
found
antibodi
transmiss
lice
flea
consid
unlik
transplacent
transmiss
occur
fip
found
kitten
stillborn
weak
newborn
kitten
born
queen
fip
later
stage
pregnanc
mode
transmiss
uncommon
natur
circumst
howev
kitten
remov
contact
adult
virusshed
cat
week
age
becom
infect
commonli
kitten
infect
age
week
time
matern
antibodi
wane
mostli
contact
fece
mother
fcovexcret
cat
fcov
shed
mainli
fece
earli
infect
may
found
saliva
viru
replic
tonsil
possibl
respiratori
secret
urin
like
naiv
cat
multiplecat
household
first
encount
fcov
becom
infect
develop
antibodi
probabl
shed
viru
period
week
month
extrem
sensit
revers
transcriptas
rt
polymeras
chain
reaction
pcr
techniqu
shown
mani
natur
infect
healthi
carrier
cat
shed
fcov
least
month
cat
shed
viru
intermitt
becom
chronic
fcov
shedder
year
lifelong
provid
continu
sourc
reinfect
cat
cat
antibodyneg
unlik
shed
wherea
approxim
one
third
fcov
antibodyposit
cat
shed
viru
shown
cat
high
antibodi
titer
like
shed
fcov
shed
consist
higher
amount
viru
thu
height
titer
directli
correl
viru
replic
amount
viru
intestin
cat
fip
also
shed
nonmut
fcov
howev
viru
load
fece
seem
decreas
cat
develop
fip
nonmut
fcov
replic
enterocyt
caus
asymptomat
infect
diarrhea
wherea
mutat
fcov
replic
macrophag
lead
fip
believ
avirul
fcov
remain
confin
digest
tract
could
cross
gut
mucosa
spread
beyond
intestin
epithelium
region
lymph
node
wherea
fipcaus
fcov
dissemin
organ
like
via
bloodborn
monocyt
fcov
detect
blood
use
rtpcr
howev
cat
fip
healthi
cat
household
endem
fcov
never
develop
fip
indic
nonmut
fcov
may
also
caus
viremia
like
viremia
cat
develop
fip
may
short
term
low
grade
cat
becom
infect
fcov
ingest
rare
inhal
main
site
viral
replic
intestin
epithelium
specif
receptor
fcov
least
fcov
serotyp
enzym
aminopeptidasen
found
intestin
brush
border
replic
fcov
cytoplasm
caus
destruct
intestin
epithelium
cell
cat
may
sometim
develop
diarrhea
depend
degre
viru
replic
mani
cat
infect
persist
long
period
without
caus
clinic
sign
cat
shed
fcov
intermitt
continu
act
sourc
infect
cat
fip
infecti
sporad
diseas
caus
viru
variant
develop
within
specif
cat
occurr
mutat
fip
develop
spontan
mutat
certain
region
fcov
genom
gene
discuss
import
whenev
fcov
infect
exist
potenti
develop
fip
critic
mutat
alway
occur
gene
exact
locat
vari
comparison
genom
mutat
viru
parent
viru
reveal
homolog
mutat
lead
chang
surfac
structur
viru
allow
viru
phagocyt
macrophag
bind
ribosom
macrophag
thu
mutat
viru
contrast
harmless
rel
sudden
abl
replic
within
macrophag
consid
key
event
pathogenesi
fip
decreas
suppress
viru
intestin
immun
system
may
allow
increas
viru
replic
turn
predispos
cat
fip
develop
increas
viru
load
increas
viru
replic
make
occurr
virul
mutat
like
factor
increas
fcov
replic
intestin
increas
probabl
mutat
occur
factor
includ
physic
characterist
eg
young
age
breed
predisposit
immun
statu
cat
may
compromis
infect
eg
felin
immunodefici
viru
fiv
felv
infect
stress
glucocorticoid
treatment
surgeri
well
dosag
virul
viru
reinfect
rate
multiplecat
household
like
kitten
develop
fip
subject
larg
viru
dose
time
life
still
undevelop
immun
system
also
cope
infect
stress
vaccin
reloc
neuter
question
one
cat
develop
fip
mani
other
subject
intens
research
recent
studi
fail
detect
correl
genet
differ
felin
leukocyt
antigen
complex
class
ii
polymorph
suscept
fip
fip
immun
complex
diseas
involv
viru
viral
antigen
antivir
antibodi
complement
viru
caus
major
damag
cat
immun
reaction
lead
fatal
consequ
within
approxim
day
mutat
occur
mutat
virus
distribut
macrophag
whole
bodi
found
cecum
colon
intestin
lymph
node
spleen
liver
central
nervou
system
cn
two
possibl
explan
event
occur
viral
dissemin
intestin
first
propos
mechan
fcovinfect
macrophag
leav
bloodstream
enabl
viru
enter
tissu
viru
attract
antibodi
complement
fix
macrophag
neutrophil
attract
lesion
consequ
typic
granulomat
chang
develop
altern
explan
fip
occur
result
circul
immun
complex
exit
circul
blood
vessel
wall
fix
complement
lead
develop
granulomat
chang
assum
antigen
antibodi
complex
recogn
macrophag
present
killer
cell
thu
destroy
consequ
format
immun
complex
cat
depend
size
antibodi
concentr
antigen
content
immun
complex
deposit
like
occur
site
high
blood
pressur
turbul
condit
occur
blood
vessel
bifurc
fip
lesion
common
peritoneum
kidney
uvea
site
high
blood
pressur
turbul
viru
chemotact
substanc
includ
complement
inflammatori
mediat
releas
infect
die
macrophag
complement
fixat
lead
releas
vasoact
amin
caus
endotheli
cell
retract
thu
increas
vascular
permeabl
retract
capillari
endotheli
cell
allow
exud
plasma
protein
henc
develop
characterist
proteinrich
exud
inflammatori
mediat
activ
proteolyt
enzym
caus
tissu
damag
immunemedi
vascul
lead
activ
coagulatori
system
dissemin
intravascular
coagul
dic
imbal
certain
cytokin
eg
increas
tumor
necrosi
factora
tnfa
decreas
interferonc
found
earli
experiment
induc
fip
acutephas
protein
alter
cat
fip
suggest
increas
acutephas
protein
acid
glycoprotein
chang
glycosyl
play
role
pathogenesi
fip
tissu
distribut
acid
glycoproteinrel
protein
howev
depend
presenc
fcov
suggest
protein
directli
involv
pathogenesi
fip
mani
infecti
diseas
preexist
antibodi
protect
subsequ
challeng
experiment
induc
fip
howev
enhanc
form
diseas
may
occur
cat
alreadi
preexist
antibodi
propos
mechan
socal
antibodydepend
enhanc
ade
antibodi
facilit
uptak
fcov
macrophag
ade
higher
proport
antibodyposit
cat
die
compar
antibodyneg
control
antibodyposit
cat
develop
diseas
earlier
day
compar
day
control
find
complic
search
effect
safe
vaccin
ade
occur
vaccin
mani
vaccin
experi
ade
seem
play
major
role
field
howev
antibodyposit
pet
cat
natur
reinfect
fcov
show
evid
ade
clinic
sign
total
depend
whether
virul
mutat
occur
initi
fcov
infect
may
short
episod
upper
respiratori
tract
sign
although
sign
usual
sever
enough
warrant
veterinari
attent
fcov
infect
caus
transient
clinic
mild
diarrhea
vomit
result
replic
fcov
enterocyt
kitten
infect
fcov
gener
commonli
develop
diarrhea
sometim
histori
stunt
growth
occasion
upper
respiratori
tract
sign
rare
viru
respons
sever
acut
chronic
vomit
diarrhea
weight
loss
may
unrespons
treatment
continu
month
fcovinfect
cat
howev
asymptomat
clinic
sign
fip
variabl
mani
organ
includ
liver
kidney
pancrea
eye
well
cn
involv
clinic
sign
patholog
find
occur
fip
direct
consequ
vascul
organ
failur
result
damag
blood
vessel
suppli
cat
nonspecif
clinic
sign
chronic
weight
loss
fever
unknown
origin
resist
antibiot
treatment
recurr
natur
fip
list
differenti
diagnos
case
natur
infect
exact
durat
time
mutat
develop
clinic
sign
unknown
almost
certainli
depend
immun
system
individu
cat
like
diseas
becom
appar
week
year
mutat
occur
time
infect
harmless
fcov
develop
fip
even
unpredict
depend
event
spontan
mutat
shown
cat
greatest
risk
develop
fip
first
month
infect
fcov
risk
fall
approxim
month
infect
three
differ
form
fip
identifi
effus
exud
wet
form
noneffus
nonexud
dri
granulomat
parenchymat
form
mix
form
first
form
character
fibrin
periton
pleuriti
pericard
effus
abdomen
thorax
andor
pericardium
respect
second
form
without
obviou
effus
character
granulomat
chang
differ
organ
includ
eye
well
cn
meantim
shown
differenti
form
use
valu
diagnost
approach
alway
effus
greater
lesser
degre
combin
less
granulomat
organ
chang
present
cat
fip
addit
form
transform
fip
thu
simpli
less
exud
product
certain
cat
given
time
point
mani
cat
fip
develop
effus
cat
effus
ascit
fig
thorac
effus
andor
pericardi
effus
survey
cat
fip
effus
ascit
thorac
effus
effus
bodi
caviti
nevertheless
import
consid
cat
effus
less
actual
fip
studi
includ
cat
effus
caus
variou
reason
approxim
cat
thorac
effus
cat
abdomin
thorac
effus
fip
cat
ascit
approxim
fip
cat
ascit
abdomin
swell
commonli
notic
owner
sometim
may
confus
pregnanc
fluctuat
fluid
wave
may
present
less
sever
case
fluid
palpat
intestin
loop
abdomin
mass
may
sometim
palpat
reflect
oment
viscer
adhes
enlarg
mesenter
lymph
node
thorac
effus
usual
manifest
dyspnea
tachypnea
sometim
openmouth
breath
cyanot
mucou
membran
auscult
reveal
muffl
heart
sound
pericardi
effus
may
present
addit
without
effus
cat
heart
sound
muffl
typic
chang
seen
ekg
echocardiographi
one
survey
fip
account
cat
pericardi
effus
second
congest
heart
failur
cat
effus
may
bright
alert
wherea
other
depress
cat
eat
normal
even
increas
appetit
wherea
other
anorect
cat
fever
show
weight
loss
sign
organ
failur
present
addit
effus
eg
icteru
effus
visual
diagnost
imag
eg
radiograph
ultrasound
presenc
verifi
tap
fluid
cat
without
effus
sign
often
vagu
includ
fever
weight
loss
lethargi
decreas
appetit
cat
may
icter
lung
involv
cat
may
dyspneic
thorac
radiograph
may
reveal
patchi
densiti
lung
abdomin
palpat
may
reveal
enlarg
mesenter
lymph
node
irregular
kidney
nodular
irregular
viscera
present
clinic
sign
unusu
cat
abdomin
tumor
suspect
fip
final
diagnos
necropsi
cat
present
gastrointestin
obstruct
one
case
report
cat
suffer
necrot
orchiti
fip
sign
although
believ
reproduct
disord
neonat
death
fade
kitten
usual
associ
fip
sometim
main
organ
affect
granulomat
chang
intestin
lesion
commonli
found
ileocecocol
junction
may
also
present
area
eg
colon
small
intestin
cat
may
varieti
clinic
sign
result
lesion
commonli
chronic
diarrhea
sometim
vomit
obstip
also
occur
palpat
abdomen
often
reveal
thicken
intestin
area
hematolog
sometim
show
increas
number
heinz
bodi
result
decreas
absorpt
vitamin
b
cat
fip
frequent
ocular
lesion
common
obviou
ocular
lesion
retin
chang
therefor
retin
examin
perform
cat
fip
suspect
fip
caus
cuf
retin
vasculatur
appear
fuzzi
grayish
line
either
side
blood
vessel
occasion
granulomat
chang
seen
retina
retin
hemorrhag
detach
may
also
occur
chang
howev
pathognomon
similar
chang
seen
system
infecti
diseas
includ
toxoplasmosi
system
fungu
infect
fiv
felv
infect
anoth
common
manifest
uveiti
fig
uveiti
inflamm
uveal
coat
eye
consist
iri
ciliari
bodi
choroid
vessel
uveal
coat
seed
immunolog
compet
cell
migrat
eye
eye
thu
undergo
type
immunolog
mediat
inflamm
mild
uveiti
manifest
color
chang
iri
usual
part
iri
becom
brown
although
blue
eye
occasion
appear
green
uveiti
may
also
manifest
aqueou
flare
cloudi
anterior
chamber
sometim
detect
darken
room
use
focal
illumin
larg
number
inflammatori
cell
anterior
chamber
settl
back
cornea
caus
kerat
precipit
may
hidden
nictit
membran
cat
hemorrhag
anterior
chamber
aqueou
humor
tap
may
reveal
elev
protein
pleocytosi
fip
common
reason
neurolog
disord
cat
retrospect
studi
cat
neurolog
sign
half
cat
largest
diseas
categori
inflammatori
diseas
fip
cat
fip
approxim
neurolog
sign
variabl
reflect
area
cn
involv
usual
lesion
multifoc
common
clinic
sign
ataxia
follow
nystagmu
seizur
addit
incoordin
intent
tremor
hyperesthesia
behavior
chang
cranial
nerv
defect
seen
cranial
nerv
involv
neurolog
sign
like
visual
deficit
loss
menac
reflex
may
present
depend
cranial
nerv
damag
fip
lesion
locat
peripher
nerv
spinal
column
lame
progress
ataxia
tetraparesi
hemiparesi
paraparesi
may
observ
studi
cat
fip
neurolog
involv
found
hydrocephalu
postmortem
examin
find
hydrocephalu
ct
scan
suggest
neurolog
fip
diseas
cryptococcosi
toxoplasmosi
lymphoma
report
caus
find
diagnos
enter
fcov
perform
rtpcr
fece
electron
microscopi
fecal
sampl
intestin
biopsi
limit
valu
histopatholog
featur
villu
tip
ulcer
stunt
fusion
nonspecif
fcov
infect
caus
diarrhea
confirm
immunohistochem
immunofluoresc
stain
intestin
biopsi
posit
definit
diagnos
fip
antemortem
extrem
challeng
mani
clinic
case
fip
often
misdiagnos
mani
time
gener
clinic
sign
eg
chronic
fever
weight
loss
anorexia
malais
nonspecif
fast
reliabl
diagnosi
would
critic
prognost
reason
avoid
suffer
patient
difficulti
definit
diagnos
fip
howev
aris
unspecif
clinic
sign
lack
pathognomon
hematolog
biochem
abnorm
low
sensit
specif
test
routin
use
practic
diagnost
valu
frequent
use
paramet
known
experiment
set
test
wide
use
clinic
patient
weight
score
system
fip
diagnosi
take
sever
paramet
account
includ
background
cat
histori
presenc
clinic
sign
laboratori
chang
height
antibodi
titer
suggest
howev
lead
certain
score
percentag
likelihood
fip
thu
help
confirm
diagnosi
definit
howev
certain
test
avail
meantim
eg
stain
antigen
macrophag
effus
tissu
least
case
posit
result
confirm
diagnosi
fip
number
laboratori
chang
common
cat
fip
pathognomon
howev
fip
diagnos
base
find
blood
cell
count
often
chang
cat
fip
howev
chang
pathognomon
white
blood
cell
decreas
increas
although
often
state
lymphopenia
neutrophilia
typic
fip
chang
interpret
typic
stress
leukogram
occur
mani
sever
system
diseas
cat
cat
fip
anemia
present
usual
mild
decreas
hematocrit
anemia
regen
case
caus
mainli
secondari
autoimmun
hemolyt
anemia
aiha
autoantibodi
erythrocyt
found
coomb
test
result
posit
cat
sever
intestin
chang
heinz
bodi
found
larg
number
erythrocyt
also
lead
hemolysi
altern
anemia
nonregen
mainli
caus
anemia
associ
chronic
inflamm
approxim
cat
fip
nonspecif
reactiv
chang
bone
marrow
necropsi
thrombocytopenia
commonli
found
cat
fip
result
dic
experiment
infect
thrombocytopenia
detect
earli
day
infect
paramet
indic
dic
includ
fibrinogen
degrad
product
fdp
ddimer
also
commonli
increas
consist
laboratori
find
cat
fip
increas
total
serum
protein
concentr
found
approxim
cat
effus
cat
without
effus
increas
total
protein
caus
increas
globulin
mainli
cglobulin
also
lead
decreas
albumintoglobulin
ratio
experiment
infect
earli
increas
globulin
report
wherea
cglobulin
antibodi
titer
increas
appear
clinic
sign
characterist
high
level
cglobulin
increas
antibodi
titer
invit
conclus
hypergammaglobulinemia
caus
specif
antifcov
immun
respons
antibodi
titer
hypergammaglobulinemia
show
linear
correl
wide
variat
antifcov
titer
given
concentr
cglobulin
indic
addit
autoimmun
reaction
occur
pathogenesi
fip
discuss
stimul
b
cell
produc
part
diseas
process
addit
contribut
increas
cglobulin
total
protein
cat
fip
reach
high
concentr
gdl
gl
howev
reflect
chronic
antigen
stimul
gener
caus
chronic
infect
cat
abl
clear
immun
respons
even
serum
total
protein
concentr
gl
greater
likelihood
fip
cat
high
serum
protein
concentr
fip
may
suffer
sever
chronic
stomat
chronic
upper
respiratori
diseas
dirofilariasi
multipl
myeloma
recent
studi
cat
fip
comparison
total
serum
protein
concentr
cglobulin
albumintoglobulin
ratio
reveal
albumintoglobulin
ratio
statist
significantli
better
diagnost
valu
two
paramet
thu
increas
globulin
decreas
albumin
concentr
seem
characterist
fip
decreas
serum
albumin
occur
decreas
product
liver
failur
protein
loss
protein
loss
attribut
glomerulopathi
caus
immun
complex
deposit
loss
protein
caus
exud
enteropathi
case
granulomat
chang
intestin
loss
proteinrich
fluid
vascul
also
explain
decreas
product
liver
without
compromis
liver
function
albumin
globulin
contribut
although
importantli
plasma
oncot
pressur
thu
increas
globulin
may
caus
neg
feedback
albumin
product
liver
optimum
cutoff
valu
maximum
effici
determin
albumintoglobulin
ratio
serum
albumintoglobulin
ratio
less
probabl
cat
fip
high
posit
predict
valu
albumintoglobulin
ratio
higher
cat
like
fip
neg
predict
valu
electrophoresi
often
perform
ration
behind
quantifi
cglobulin
distinguish
polyclon
monoclon
hypergammaglobulinemia
differenti
fip
chronic
infect
tumor
like
multipl
myeloma
plasma
cell
tumor
quantif
cglobulin
use
measur
total
protein
howev
addit
polyclon
monoclon
hypergammaglobulinemia
occur
cat
fip
true
multipl
myeloma
thu
valu
electrophoresi
limit
laboratori
paramet
eg
liver
enzym
bilirubin
urea
creatinin
variabl
increas
depend
degre
local
organ
damag
help
make
etiolog
diagnosi
hyperbilirubinemia
icteru
often
observ
frequent
reflect
hepat
necrosi
despit
fact
alkalin
phosphatas
alp
alanin
aminotransferas
alt
activ
often
increas
dramat
liver
diseas
cholangiohepat
hepat
lipidosi
hyperbilirubinemia
caus
rare
hemolysi
result
secondari
aiha
howev
hemolysi
sever
caus
icteru
bilirubin
sometim
increas
cat
fip
without
evid
hemolysi
liver
diseas
cholestasi
specul
bilirubin
metabol
excret
biliari
system
compromis
cat
fip
similar
find
sepsi
measur
l
acid
glycoprotein
may
help
diagnosi
fip
acutephas
protein
increas
sever
infecti
diseas
cat
thu
specif
fip
nevertheless
l
acid
glycoprotein
level
plasma
effus
usual
greater
lgml
cat
fip
may
help
distinguish
fip
clinic
similar
condit
effus
import
diagnost
step
sampl
fluid
test
effus
much
higher
diagnost
valu
test
perform
use
blood
thu
fluid
collect
blood
taken
avoid
wast
money
expens
blood
test
approxim
half
cat
effus
suffer
fip
thu
although
effus
clear
yellow
color
sticki
consist
often
call
typic
presenc
type
fluid
bodi
caviti
alon
diagnost
fig
effus
fip
may
clear
strawcolor
viscou
may
froth
shake
high
protein
content
effus
may
clot
store
refriger
sampl
bloodi
pu
fill
foul
smell
chylu
fip
less
like
although
effus
fip
differ
sometim
red
pink
almost
colorless
appear
case
cat
fip
pure
chylu
effus
even
report
effus
fip
usual
classifi
modifi
transud
exud
typic
combin
characterist
transud
exud
protein
content
usual
high
gl
reflect
composit
serum
wherea
cellular
content
low
approach
pure
transud
nucleat
cell
per
millilit
protein
content
effus
high
high
concentr
cglobulin
diseas
caus
similar
effus
includ
lymphoma
heart
failur
cholangiohepat
bacteri
periton
pleuriti
measur
enzym
activ
effus
also
indic
fip
might
underli
diseas
lactat
dehydrogenas
ldh
typic
high
iul
effus
caus
fip
releas
inflammatori
cell
activ
aamylas
also
often
high
like
result
common
pancreat
involv
enzym
adenosin
deaminas
ad
use
distinguish
differ
caus
effus
activ
significantli
high
cat
fip
cytolog
evalu
effus
cat
fip
typic
show
pyogranulomat
charact
predominantli
macrophag
neutrophil
fig
cytolog
find
may
appear
similar
cat
bacteri
seros
sometim
lymphoma
effus
often
differenti
howev
presenc
malign
cell
bacteria
respect
bacteri
cultur
perform
unclear
case
simpl
test
socal
rivalta
test
fig
use
differenti
transud
exud
test
origin
develop
italian
research
name
rivalta
around
use
differenti
transud
exud
human
patient
method
replac
test
human
medicin
limit
diagnost
valu
peopl
shown
diagnost
help
dog
effus
nevertheless
test
seem
use
cat
differenti
effus
caus
fip
effus
caus
diseas
high
protein
content
high
concentr
fibrin
inflammatori
mediat
induc
posit
reaction
perform
test
three
quarter
reagent
tube
fill
distil
water
one
drop
acet
acid
ad
mix
thoroughli
surfac
solut
one
drop
effus
fluid
care
layer
drop
disappear
solut
remain
clear
rivalta
test
result
defin
neg
drop
retain
shape
stay
attach
surfac
slowli
float
bottom
tube
droplik
jellyfishlik
rivalta
test
result
defin
posit
fig
typic
cytolog
effus
cat
fip
recent
studi
rivalta
test
posit
predict
valu
neg
predict
valu
falseposit
result
cat
bacteri
periton
effus
howev
usual
easi
differenti
macroscop
examin
cytolog
bacteri
cultur
cat
lymphoma
also
posit
rivalta
test
result
mani
case
differenti
cytolog
overal
rivalta
test
easi
inexpens
method
requir
special
laboratori
equip
easili
perform
privat
practic
provid
good
predict
valu
thu
help
diagnost
test
analysi
cerebrospin
fluid
csf
cat
neurolog
sign
caus
fip
lesion
may
reveal
elev
protein
mgdl
normal
valu
less
mgdl
pleocytosi
nucleat
cell
per
millilit
contain
mainli
neutrophil
lymphocyt
macrophag
rel
nonspecif
find
howev
mani
cat
fip
neurolog
sign
normal
csf
tap
antibodi
titer
measur
serum
extens
use
diagnost
tool
view
fact
larg
percentag
healthi
cat
popul
fcov
antibodyposit
high
rise
titer
frequent
found
asymptomat
cat
cat
never
develop
fip
antibodi
titer
must
interpret
extrem
cautious
time
first
fip
test
describ
two
decad
ago
present
inadequaci
pitfal
test
topic
continu
discuss
controversi
meanwhil
socal
fip
test
refer
felin
coronaviru
antibodi
test
emphas
latter
correctli
describ
antibodi
detect
react
larg
group
close
relat
coronavirus
time
clinician
mistakenli
taken
posit
titer
equat
diagnosi
fip
assum
cat
die
fcov
antibodi
test
fip
fcov
test
often
perform
inappropri
reason
five
major
indic
test
fcov
antibodi
diagnosi
fcovinduc
enter
narrow
diagnosi
fip
healthi
cat
contact
suspect
known
excretor
fcov
catbreed
facil
aim
obtain
fcovfre
environ
screen
catteri
presenc
fcov
screen
cat
introduct
fcovfre
catteri
although
frequent
critic
antibodi
test
certain
role
diagnosi
importantli
manag
fcov
infect
perform
appropri
methodolog
result
properli
interpret
antibodi
test
use
laboratori
reliabl
consist
methodolog
antibodi
titer
result
may
vari
significantli
singl
serum
sampl
divid
sent
five
differ
laboratori
unit
state
yield
five
differ
result
antigen
use
test
exampl
play
import
role
test
sensit
specif
eg
antigen
use
test
deriv
nonfelin
virus
practic
mani
commerci
laboratori
thu
essenti
antibodi
result
interpret
compar
clinician
alway
obtain
method
perform
laboratori
essenti
use
antibodi
test
valid
scientif
commun
evalu
titer
antibodi
give
idea
amount
antibodi
present
contrast
test
eg
inhous
test
indic
presenc
antibodi
without
quantif
use
also
produc
high
number
falseposit
falseneg
result
choic
laboratori
use
critic
perform
quantit
titer
evalu
use
laboratori
establish
two
level
one
least
signific
level
reactiv
lowest
posit
titer
highest
antibodi
titer
valu
search
reliabl
laboratori
repeat
sampl
anim
sent
without
warn
laboratori
fcovreferenc
laboratori
comparison
enabl
use
interpret
serum
plasma
sampl
store
well
c
without
loss
antibodi
concentr
presenc
antibodi
indic
fip
absenc
antibodi
exclud
fip
mani
author
agre
low
medium
titer
diagnost
valu
approxim
cat
clinic
manifest
fip
neg
result
shown
cat
fulmin
fip
titer
decreas
termin
cat
effus
sometim
low
titer
even
antibodi
larg
amount
viru
cat
bodi
bind
antibodi
render
unavail
bind
antigen
antibodi
test
antibodi
lost
effus
protein
transloc
vascul
extrem
high
titer
certain
diagnost
valu
highest
measur
titer
present
cat
thu
import
know
highest
titer
specif
laboratori
increas
likelihood
fip
recent
studi
probabl
fip
cat
highest
titer
investig
cat
popul
fip
suspect
diagnost
valu
high
titer
also
depend
background
cat
highest
titer
cat
come
multiplecat
household
situat
extrem
predict
household
fcov
endem
mani
cat
high
titer
wherea
highest
titer
cat
singlecat
environ
unusu
stronger
indic
fip
although
antibodi
test
sick
cat
suspect
fip
limit
valu
number
situat
antibodi
test
use
tool
healthi
cat
antibodi
consid
like
free
fcov
thu
infecti
other
shed
fcov
develop
fip
shown
height
antibodi
titer
directli
correl
amount
viru
shed
fece
cat
high
antibodi
titer
like
shed
fcov
shed
consist
higher
amount
viru
thu
height
titer
directli
correl
viru
replic
rate
amount
viru
intestin
antibodi
measur
import
common
situat
practic
cat
present
contact
cat
fip
suspect
known
viru
excretor
owner
want
know
prognosi
expos
cat
wish
obtain
anoth
cat
need
know
whether
expos
cat
shed
fcov
also
cat
breeder
may
request
test
goal
creat
fcovfre
catteri
screen
catteri
presenc
fcov
screen
cat
introduct
fcovfre
catteri
also
import
indic
studi
evalu
diagnost
valu
antibodi
detect
fluid
serum
effus
presenc
antibodi
effus
correl
presenc
antibodi
blood
studi
kennedi
et
al
antibodi
titer
effus
help
cat
studi
medium
antibodi
titer
irrespect
whether
fip
studi
hartmann
et
al
howev
presenc
antifcov
antibodi
effus
high
posit
predict
valu
high
neg
predict
valu
although
height
titer
correl
presenc
fip
measur
antibodi
effus
least
use
measur
antibodi
blood
foley
et
al
determin
diagnost
valu
antibodi
detect
csf
found
good
correl
presenc
fip
compar
histopatholog
find
wherea
studi
boettcher
et
al
signific
differ
antibodi
titer
csf
cat
neurolog
sign
caus
fip
compar
cat
neurolog
diseas
confirm
histopatholog
find
compar
serolog
rtpcr
provid
obviou
advantag
directli
detect
ongo
infect
rather
document
previou
immun
system
encount
coronaviru
rtpcr
perform
reversetranscrib
coronaviru
rna
cdna
make
larg
quantiti
dna
visual
detect
although
fipcaus
virus
genet
mutant
harmless
enter
fcov
numer
site
exist
gene
mutat
delet
confer
viru
capabl
infect
replic
within
macrophag
sometim
chang
singl
rna
base
result
pcr
primer
discrimin
fipcaus
virus
harmless
enter
fcov
design
possibl
distinguish
mutat
nonmut
viru
pcr
number
reason
rtpcr
result
alway
easi
interpret
sever
plausibl
explan
falseneg
pcr
result
assay
requir
revers
transcript
viral
rna
dna
amplif
dna
degrad
rna
could
potenti
problem
rnase
virtual
ubiquit
may
suffici
strain
nucleotid
sequenc
variat
target
sequenc
chosen
assay
may
detect
strain
fipv
also
number
explan
falseposit
result
first
assay
distinguish
virul
avirul
fcov
strain
differenti
fcov
ccv
tgev
although
role
virus
field
unknown
cat
experiment
infect
ccv
tgev
infect
could
result
posit
pcr
result
second
recent
studi
support
hypothesi
viremia
occur
cat
fip
healthi
carrier
fcov
rna
could
detect
blood
cat
fip
well
blood
healthi
cat
develop
fip
period
month
studi
gunnmoor
et
al
shown
household
fcov
endem
cat
virem
irrespect
health
statu
presenc
viremia
seem
predispos
cat
develop
fip
therefor
result
pcr
test
must
interpret
conjunct
clinic
find
use
sole
criterion
diagnos
fip
rtpcr
effus
discuss
interest
diagnost
tool
data
use
approach
limit
howev
far
one
studi
includ
inform
rtpcr
ascit
fluid
limit
number
cat
report
studi
six
six
cat
confirm
fip
posit
rtpcr
result
one
one
cat
ascit
caus
anoth
diseas
neg
rtpcr
result
number
howev
suffici
judg
approach
suffici
csf
recommend
rtpcr
may
contain
low
number
viru
also
cat
fip
bloodbrain
barrier
compromis
accur
studi
need
howev
rtpcr
use
detect
fcov
fecal
sampl
sensit
use
document
cat
shed
fcov
fece
cat
vari
much
fcov
shed
fece
repeat
pcr
perform
daili
day
detect
accur
whether
given
cat
shed
fcov
sampl
rtpcr
must
care
handl
kept
frozen
protect
rnadegrad
enzym
ubiquit
environ
pcr
perform
quickli
possibl
collect
even
sampl
frozen
delay
test
may
result
falseneg
result
posit
rtpcr
result
fecal
sampl
document
fcov
infect
strength
pcr
signal
fece
correl
amount
viru
present
intestin
fip
immunemedi
diseas
antibodi
antigen
complex
play
import
role
suggest
look
circul
complex
serum
effus
antibodi
antigen
complex
detect
perform
use
competit
elisa
use
howev
limit
posit
predict
valu
test
high
one
studi
mani
falseposit
result
method
detect
viru
includ
search
presenc
fcov
antigen
fig
studi
parodi
et
al
immunofluoresc
assay
detect
intracellular
fcov
antigen
cell
within
effus
use
howev
number
cat
enrol
studi
limit
hirschberg
et
al
detect
fcov
antigen
sampl
cat
fipinduc
effus
recent
studi
involv
larg
number
cat
immunofluoresc
stain
intracellular
fcov
antigen
macrophag
effus
posit
predict
valu
falseposit
result
mean
stain
test
posit
predict
cat
fip
unfortun
neg
predict
valu
high
case
stain
neg
although
cat
fip
explain
fact
number
macrophag
effus
smear
sometim
insuffici
anoth
explan
potenti
mask
antigen
competit
bind
fcov
antibodi
effus
displac
bind
fluoresc
antibodi
immunohistochemistri
also
use
detect
express
fcov
antigen
tissu
tammer
et
al
use
immunohistochemistri
detect
intracellular
fcov
antigen
paraffinembed
tissu
euthan
cat
found
fcov
antigen
macrophag
cat
fip
control
cat
abl
demonstr
fcov
antigen
membrana
nictitan
cat
fip
shown
posit
stain
macrophag
effus
predict
fip
seem
true
immunohistochem
stain
tissu
macrophag
immunostain
differenti
harmless
nonmut
fcov
mutat
fipcaus
fcov
obvious
fipcaus
viru
abl
replic
suffici
larg
amount
macrophag
result
posit
stain
therefor
addit
histopatholog
pathognomon
lesion
present
detect
intracellular
fcov
antigen
immunofluoresc
immunohistochemistri
way
diagnos
fip
definit
tool
use
whenev
possibl
diagnosi
fip
establish
mani
case
histopatholog
test
biopsi
necropsi
sampl
hematoxylin
eosinstain
sampl
typic
contain
local
perivascular
mix
inflamm
macrophag
neutrophil
lymphocyt
plasma
cell
pyogranuloma
may
larg
consolid
sometim
focal
tissu
necrosi
numer
small
lymphoid
tissu
cat
fip
often
show
lymphoid
deplet
caus
apoptosi
histolog
test
diagnost
stain
antigen
macrophag
detect
nucleic
acid
tissu
use
confirm
fip
fig
virtual
everi
cat
confirm
fip
die
fast
reliabl
diagnosi
fip
differenti
harmless
enter
fcov
infect
crucial
prognost
reason
indic
treatment
healthi
antibodyposit
cat
would
prevent
develop
fip
treatment
corticosteroid
conceiv
prevent
clinic
sign
occur
mutat
occur
certain
period
time
immun
suppress
might
opposit
effect
precipit
clinic
fip
increas
risk
mutat
mutat
occur
yet
thu
immun
suppress
contraind
long
cat
infect
harmless
fcov
stress
import
factor
develop
fip
avoid
unnecessari
stress
rehom
elect
surgeri
placement
board
catteri
may
benefici
ifn
eg
felin
ifnx
avail
commerci
europ
japan
discuss
situat
control
studi
miss
date
case
diarrhea
caus
nonmut
fcov
selflimit
cat
chronic
diarrhea
antibodi
fcov
possibl
caus
elimin
fcov
detect
fece
electron
microscopi
treat
support
fluid
electrolyt
replac
dietari
intervent
treatment
lactulos
live
natur
yogurt
may
benefici
regul
intestin
bacteri
flora
increas
passag
time
specif
antivir
treatment
yet
demonstr
cure
condit
case
challeng
sometim
difficult
distinguish
cat
fip
manifest
sole
granulomat
chang
intestin
lead
diarrhea
fip
diarrhea
treat
immun
suppress
identifi
convers
contraind
harmless
fcov
infect
case
cat
usual
antibodi
sometim
high
titer
differenti
exploratori
surgeri
avoid
cat
harmless
intestin
fcov
infect
treatment
fip
almost
invari
doom
failur
cat
clinic
fip
eventu
die
cat
milder
clinic
sign
may
surviv
sever
month
enjoy
qualiti
life
treatment
howev
clinic
sign
becom
debilit
weight
appetit
declin
owner
must
prepar
realiti
cat
die
fip
immunemedi
diseas
treatment
aim
control
immun
respons
fcov
success
treatment
consist
rel
high
dose
immunosuppress
antiinflammatori
drug
immunosuppress
drug
prednison
mgkg
administ
oral
everi
hour
cyclophosphamid
mgkg
administ
oral
four
consecut
day
everi
week
may
slow
diseas
progress
produc
cure
cat
effus
benefit
tap
remov
fluid
inject
dexamethason
mgkg
abdomin
thorac
caviti
everi
hour
effus
produc
anymor
cat
fip
also
treat
broadspectrum
antibiot
support
therapi
eg
subcutan
fluid
long
comfort
thromboxan
synthetas
inhibitor
ozagrel
hydrochlorid
inhibit
platelet
aggreg
use
cat
led
improv
clinic
sign
veterinarian
prescrib
immun
modul
eg
propionibacterium
acn
acemannan
treat
cat
fip
document
control
evid
efficaci
immun
modul
ifn
induc
wide
use
induc
synthesi
ifn
cytokin
suggest
agent
may
benefit
infect
anim
restor
compromis
immun
function
therebi
allow
patient
control
viral
burden
recov
diseas
nonspecif
stimul
immun
system
contraind
howev
cat
fip
clinic
sign
develop
progress
result
immunemedi
respons
mutat
fcov
search
effect
antivir
treatment
cat
fip
unfortun
success
although
sever
studi
perform
ribavirin
rtca
broadspectrum
triazol
nucleosid
mark
vitro
antivir
activ
varieti
dna
rna
virus
includ
fcov
ribavirin
nucleosid
analogu
contrast
common
antivir
compound
act
primarili
inhibit
polymeras
ribavirin
allow
dna
rna
synthesi
occur
prevent
format
viral
protein
like
interf
cap
viral
mrna
vivo
therapeut
concentr
difficult
achiev
toxic
cat
extrem
sensit
side
effect
although
activ
fcov
vitro
ribavirin
effect
treatment
cat
fip
one
studi
ribavirin
administ
mgkg
oral
intramuscularli
intraven
everi
hour
day
specif
pathogenfre
kitten
hour
experiment
challeng
exposur
fipcaus
viru
kitten
includ
ribavirintr
untreat
kitten
succumb
fip
clinic
sign
diseas
even
sever
ribavirintr
kitten
mean
surviv
time
shorten
common
side
effect
cat
report
sever
studi
alreadi
use
low
dose
mgkg
hemolysi
develop
result
sequestr
drug
red
blood
cell
addit
doserel
toxic
effect
bone
marrow
occur
primarili
megakaryocyt
result
thrombocytopenia
hemorrhag
erythroid
precursor
later
higher
dosag
neutrophil
number
suppress
liver
toxic
also
report
weiss
et
al
tri
decreas
toxic
ribavirin
incorpor
lecithincontain
liposom
give
intraven
lower
dose
mgkg
cat
challeng
fipcaus
viru
howev
abl
reach
therapeut
concentr
regimen
human
ifna
immunomodulatori
antivir
activ
ifna
activ
mani
dna
rna
virus
includ
fcov
ifna
direct
antivir
effect
induc
gener
antivir
state
infacontain
cell
protect
viru
replic
virucid
mere
inhibit
viral
nucleic
acid
protein
synthesi
bind
specif
cell
receptor
activ
enzym
inhibit
synthesi
assembl
releas
virus
human
ifna
market
recombin
product
rhuifna
produc
clone
human
ifna
gene
express
escherichia
coli
two
common
treatment
regimen
use
human
ifna
cat
subcutan
inject
highdos
ifna
iukg
everi
hour
oral
applic
lowdos
ifna
iukg
everi
hour
given
parenter
high
dose
applic
lead
detect
serum
level
given
parenter
cat
becom
ineffect
week
develop
neutral
antibodi
human
ifna
limit
activ
studi
cat
treat
human
ifna
subcutan
cat
becam
refractori
therapi
week
respect
depend
whether
high
iukg
lower
iukg
dose
use
vitro
antivir
activ
human
ifna
fipcaus
fcov
strain
demonstr
combin
ifna
ribavirin
vitro
result
antivir
effect
significantli
greater
sum
observ
effect
ribavirin
ifna
alon
indic
synergist
interact
human
ifna
treatment
use
cat
treat
cat
control
experiment
induc
fip
receiv
ifna
p
acn
combin
placebo
prophylact
therapeut
administr
high
dose
iukg
ifna
significantli
reduc
mortal
treat
versu
untreat
cat
cat
treat
ifna
p
acn
dose
iukg
mean
surviv
time
significantli
prolong
day
oral
human
ifna
given
longer
period
antibodi
develop
given
oral
howev
ifna
inactiv
gastric
acid
like
protein
destroy
trypsin
proteolyt
enzym
duodenum
therefor
absorb
detect
blood
oral
administr
thu
direct
antivir
effect
unlik
oral
administr
instead
seem
immunomodulatori
activ
ifna
may
bind
mucos
receptor
oral
caviti
stimul
local
lymphoid
tissu
lead
cytokin
releas
lymphat
cell
oral
pharyng
area
trigger
cascad
immunolog
respons
final
act
system
tomkin
show
oral
administ
ifna
induc
cytokin
respons
buccal
mucos
lymph
node
includ
upregul
ifnc
express
downregul
studi
mice
shown
subcutan
administr
murin
ifna
antivir
effect
wherea
oral
administr
caus
immunomodulatori
effect
infect
mice
encephalomyocard
viru
result
death
mice
treat
surviv
mice
treat
murin
ifna
oral
dose
iu
per
mous
surviv
mice
given
dose
intraperiton
confirm
immun
modulatori
effect
oral
applic
therefor
lowdos
oral
ifna
treatment
use
cat
fip
immunomodulatori
activ
may
lead
progress
diseas
recent
correspond
felin
ifn
felin
ifnx
licens
use
veterinari
medicin
european
countri
japan
ifn
speci
specif
human
ifn
clearli
differ
felin
one
regard
antigen
thu
caus
antibodi
develop
anim
respect
antivir
efficaci
felin
cell
even
felin
ifnx
use
long
term
cat
develop
antibodi
addit
homolog
speci
ifn
cat
expect
effect
human
ifna
felin
ifnx
recombin
product
produc
baculovirus
contain
felin
sequenc
ifn
replic
silkworm
infect
subsequ
felin
ifnx
purifi
homogen
silkworm
prepar
data
efficaci
felin
ifnx
cat
fip
limit
fcov
replic
inhibit
felin
ifnx
vitro
one
studi
control
includ
small
number
cat
cat
suspect
fip
treat
ifnx
combin
glucocorticoid
support
care
ifnx
given
rate
iukg
subcutan
everi
hour
initi
clinic
improv
subsequ
everi
day
glucocorticoid
given
form
dexamethason
case
effus
mgkg
intrathorac
intraperiton
inject
everi
hour
prednisolon
initi
mgkg
administ
oral
everi
hour
clinic
improv
gradual
taper
mgkg
administ
everi
hour
although
cat
die
cat
surviv
period
year
initi
present
effus
even
though
control
group
studi
fip
even
confirm
surviv
cat
result
somewhat
interest
cat
effusionassoci
diseas
would
expect
surviv
year
without
proper
treatment
studi
would
certainli
interest
unfortun
prevent
fip
extrem
difficult
way
prevent
develop
fip
prevent
infect
fcov
vaccin
prevent
neither
fip
fcov
infect
effect
test
remov
strategi
ineffect
manag
fip
direct
minim
popul
impact
accur
diagnos
support
individu
affect
cat
thu
veterinarian
need
knowledg
regard
success
unsuccess
strategi
provid
use
counsel
client
differ
situat
consid
depend
environ
cat
fip
euthan
remain
cat
owner
wait
approxim
month
obtain
anoth
cat
fcov
stay
infecti
least
week
environ
cat
household
like
infect
shed
fcov
natur
circumst
cat
go
outsid
defec
buri
fece
case
viru
remain
infecti
hour
day
slightli
longer
freez
condit
domest
cat
introduc
litter
box
howev
fcov
may
surviv
sever
day
possibl
week
driedup
fece
thu
fcovshed
cat
like
better
chanc
elimin
viru
allow
go
outsid
optimum
situat
fenc
yard
common
practic
client
present
cat
veterinarian
contact
cat
fip
suspect
known
viru
excretor
owner
may
want
know
prognosi
expos
cat
may
want
obtain
anoth
cat
need
know
whether
expos
cat
shed
fcov
like
cat
antibodyposit
cat
expos
fcov
becom
infect
develop
antibodi
approxim
week
fcov
exposur
cat
howev
may
resist
fcov
infect
shown
low
number
cat
fcov
endem
multiplecat
household
continu
remain
antibodyneg
mechan
action
resist
still
unknown
owner
advis
cat
contact
like
antibodi
reassur
necessarili
associ
poor
prognosi
cat
infect
fcov
develop
fip
mani
cat
singleor
household
eventu
clear
infect
becom
antibodyneg
month
year
cat
retest
use
laboratori
everi
month
result
antibodi
test
neg
cat
expos
often
quicker
reduct
antibodi
exclud
risk
owner
advis
wait
antibodi
titer
cat
neg
obtain
new
cat
cat
howev
remain
antibodyposit
year
rise
antibodi
titer
mainten
high
level
necessarili
indic
poor
prognosi
cat
studi
follow
cat
high
titer
titer
cat
remain
high
level
least
three
occas
yet
cat
die
fip
contrast
situat
endem
infect
constantli
low
titer
highli
indic
cat
go
develop
fip
household
less
cat
spontan
natur
becom
fcovfre
household
cat
almost
imposs
viru
pass
one
individu
cat
anoth
maintain
infect
hold
true
virtual
multiplecat
household
breed
catteri
shelter
foster
home
home
cat
cat
household
develop
fip
cat
contact
cat
alreadi
expos
fcov
virtual
noth
prevent
fip
cat
contact
cat
fip
although
risk
fullsibl
litter
mate
kitten
fip
higher
likelihood
develop
fip
cat
environ
indic
certain
genet
compon
variou
tactic
use
elimin
fcov
household
reduc
number
cat
especi
kitten
less
month
old
keep
possibl
fcovcontamin
surfac
clean
minim
popul
load
fcov
antibodi
test
segreg
cat
aim
stop
exposur
approxim
one
third
antibodyposit
cat
excret
viru
thu
everi
antibodyposit
cat
consid
infecti
month
antibodi
titer
retest
determin
whether
cat
becom
neg
altern
rtpcr
test
sever
fecal
sampl
perform
detect
shedder
import
detect
chronic
fcov
carrier
remov
larg
multiplecat
environ
cat
shed
viru
fece
given
time
approxim
shed
viru
persist
approxim
immun
shed
viru
repeat
pcr
test
fece
perform
weekli
interv
month
document
carrier
cat
remain
persist
pcrposit
week
elimin
catteri
place
singlecat
environ
factor
manag
kitten
determin
whether
becom
infect
fcov
kitten
fcovshed
queen
protect
infect
matern
deriv
antibodi
week
old
earli
wean
protocol
prevent
fcov
infect
kitten
propos
addi
jarrett
consist
isol
queen
week
parturit
strict
quarantin
queen
kitten
earli
wean
week
age
procedur
base
find
queen
shed
viru
queen
stop
shed
sever
week
reexpos
even
queen
shed
young
kitten
matern
resist
viru
earli
remov
kitten
queen
prevent
infect
cat
may
succeed
prevent
infect
kitten
although
straightforward
concept
isol
queen
earli
wean
simpl
may
seem
procedur
requir
quarantin
room
procedur
absolut
ensur
new
viru
enter
advantag
isol
queen
shed
fcov
shed
low
level
clear
infect
earli
isol
singl
import
factor
number
anim
success
earli
wean
isol
fcov
control
depend
effect
quarantin
low
number
cat
cat
household
also
human
abod
easili
allow
adequ
quarantin
space
larg
number
queen
kitten
time
money
requir
maintain
quarantin
increas
proport
number
queen
litter
quarantin
studi
larg
catteri
switzerland
protocol
follow
earli
wean
fail
viral
infect
kitten
young
week
old
demonstr
clear
low
fcov
exposur
delay
infect
wherea
high
exposur
overcom
matern
deriv
immun
earli
age
two
essenti
downsid
isol
earli
wean
easi
fail
appropri
condit
maintain
addit
breeder
believ
earli
wean
exact
social
price
kitten
recognit
concern
recommend
earli
wean
undertaken
without
care
consider
fcovfre
household
requir
routin
isol
earli
wean
kitten
isol
queen
special
care
must
taken
period
week
age
social
kitten
success
earli
wean
also
monitor
continu
success
kitten
success
rear
free
fcov
antibodyneg
week
age
even
kitten
rais
free
fcov
may
becom
infect
sooner
later
therefor
object
isol
earli
wean
prevent
infect
delay
earli
wean
effect
best
kitten
taken
new
home
cat
week
age
even
howev
earli
wean
alway
success
suggest
maxim
herit
resist
fip
breed
catteri
genet
predisposit
complet
understood
howev
known
suscept
cat
approxim
twice
like
develop
fip
cat
cat
two
litter
kitten
develop
fip
cat
bred
particular
attent
paid
pedigre
male
fip
overrepres
line
breed
often
use
valuabl
tomcat
extens
elimin
anim
may
small
import
effect
improv
overal
resist
screen
catteri
presenc
fcov
import
mani
cat
hous
group
random
sampl
cat
indic
whether
fcov
endem
cat
hous
individu
may
necessari
test
cat
household
fewer
cat
new
acquisit
cat
isol
group
less
often
eventu
lose
fcov
infect
establish
antibodyneg
catteri
maintain
free
fcov
monitor
new
cat
introduc
thu
cat
screen
introduct
antibodyposit
cat
never
taken
household
cat
breeder
often
also
request
cat
screen
fcov
antibodi
mate
cat
healthi
antibodyneg
safe
mate
anoth
antibodyneg
cat
cat
antibodyposit
mate
cat
fcovfre
environ
prevent
fip
shelter
situat
virtual
imposs
unless
cat
strictli
kept
separ
cage
handl
mean
steril
handl
devic
compar
isol
unit
isol
often
effect
eas
fcov
transport
cloth
shoe
dust
cat
comparison
shelter
differ
type
handl
reveal
signific
correl
increas
number
handl
event
outsid
cage
increas
percentag
antibodyposit
cat
studi
feral
cat
test
time
brought
local
shelter
multipl
cat
kept
togeth
interv
thereaft
low
number
cat
antibodi
time
point
enter
percentag
increas
rapidli
virtual
cat
shelter
infect
fcov
shelter
manag
use
educ
commun
minim
advers
effect
fip
cat
popul
shelter
manag
written
inform
sheet
contract
inform
adopt
fcov
fip
understand
fcov
unavoid
multiplecat
environ
fip
unavoid
consequ
endem
fcov
shelter
need
optim
facil
husbandri
facil
clean
easili
viru
spread
minim
essenti
decreas
viral
load
stress
level
mani
attempt
develop
effect
vaccin
unfortun
fail
mainli
ade
nevertheless
vaccin
licens
primucel
pfizer
anim
health
incorpor
temperaturesensit
mutant
fcov
strain
replic
cool
line
upper
respiratori
tract
higher
intern
bodi
temperatur
vaccin
administ
intranas
produc
local
immun
iga
antibodi
site
fcov
first
enter
bodi
oropharynx
also
induc
cellmedi
immun
vaccin
avail
unit
state
sinc
introduc
mani
european
countri
concern
vaccin
safeti
efficaci
safeti
concern
focu
whether
vaccin
could
caus
fip
produc
ade
although
experiment
vaccin
trial
vaccin
never
appear
market
record
ade
challeng
field
studi
demonstr
intranas
vaccin
safe
two
extens
placebocontrol
doubleblind
field
trial
develop
fip
ade
immedi
side
effect
applic
sneez
vomit
diarrhea
statist
differ
vaccin
group
placebo
group
efficaci
vaccin
question
constantli
howev
experiment
studi
report
prevent
fraction
depend
investig
survey
cat
belong
cat
breeder
virtual
cat
antibodi
differ
found
develop
fip
vaccin
group
placebo
group
thu
vaccin
fcov
endem
environ
household
known
case
fip
effect
one
placebocontrol
doubleblind
trial
perform
switzerland
group
cat
contact
fcov
vaccin
small
statist
signific
reduct
number
cat
develop
fip
note
vaccin
ineffect
cat
alreadi
contact
fcov
antibodi
test
may
benefici
vaccin
one
disadvantag
cat
develop
antibodi
vaccin
thu
make
establish
control
fcovfre
household
difficult
conclus
studi
result
clearli
identifi
whether
vaccin
effect
versu
small
effect
although
margin
efficaci
vaccin
least
safe
induc
ade
concern
arisen
possibl
danger
fcov
peopl
close
antigenet
relat
coronavirus
differ
domest
anim
speci
eg
ccv
tgev
coronaviru
deriv
anim
close
contact
human
recent
caus
socal
sever
acut
respiratori
syndrom
sar
seem
threat
thousand
peopl
howev
indic
peopl
infect
fcov
